This not only demonstrated a novel degradation mechanism for PTEN by the SYNJ2BP-mediated pathway, but also provided new insights into the mechanisms of cancer and highlighted a new potential target for clinical detection. The gene discussed is SYNJ2BP; the disease is cancer.